A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 480 participants.

Also called NCT01923740

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 480 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01923740
Other papers using this trial's data
  • Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial Journal of the American College of Cardiology, 2015-12-01 DOI, PubMed 26471805

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01923740. Randomized; no masking; primary purpose other. Start 2013-07 (registry gives no type); primary completion 2015-05 (actual). Results posted on 2018-02-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)
Acronym
ABSORB CHINA
Condition
Coronary Artery Stenosis
Condition
Coronary Disease
Condition
Coronary Stenosis
Intervention (Device)
XIENCE V EECSS
Intervention (Device)
Absorb BVS System
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01923740
Content hash
e18da3531c225214c84adde1bff53581fb04914cdda541c6b51c5bc9d04b0c52